Orthofix Medical Inc.
$12.65
▼
-0.69%
2026-04-21 08:36:00
orthofix.com
NMS: OFIX
Explore Orthofix Medical Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$507.83 M
Current Price
$12.65
52W High / Low
$16.99 / $10.24
Stock P/E
—
Book Value
$11.3
Dividend Yield
—
ROCE
-12.14%
ROE
-19.34%
Face Value
—
EPS
$-2.33
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
1,605
Beta
0.82
Debt / Equity
45.3
Current Ratio
2.44
Quick Ratio
1.43
Forward P/E
14.48
Price / Sales
0.6
Enterprise Value
$618.81 M
EV / EBITDA
-100.67
EV / Revenue
0.75
Rating
Buy
Target Price
$17.25
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Glaukos Corporation | $123.8 | — | $7.27 B | — | -25.2% | -26.38% | $130.23 / $73.16 | $11.41 |
| 2. | CapsoVision, Inc. | $6.01 | — | $299.53 M | — | -185.75% | -1.85% | $15.37 / $3.43 | $0.28 |
| 3. | Cerus Corporation | $2.05 | — | $397.8 M | — | -7.17% | -25.66% | $2.96 / $1.15 | $0.33 |
| 4. | Inspire Medical Systems, Inc. | $56.97 | 11.28 | $1.64 B | — | 6.28% | 19.77% | $163.35 / $48.3 | $27.33 |
| 5. | Bio-Rad Laboratories, Inc. | $302.22 | 10.88 | $8.04 B | — | 2.17% | 10.84% | $343.12 / $211.43 | $276.16 |
| 6. | Establishment Labs Holdings Inc. | $66.93 | — | $1.96 B | — | -14.18% | -1.33% | $83.31 / $28.67 | $0.8 |
| 7. | TransMedics Group, Inc. | $113.13 | 20.39 | $3.88 B | — | 11.09% | 54.24% | $156 / $84.53 | $13.81 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 219.91 M | 205.63 M | 203.12 M | 193.65 M | 215.66 M | — |
| Operating Profit | 1.15 M | -17.47 M | -16.77 M | -49.48 M | -10.79 M | — |
| Net Profit | -2.22 M | -22.8 M | -14.08 M | -53.09 M | -29.15 M | — |
| EPS in Rs | -0.06 | -0.57 | -0.35 | -1.32 | -0.73 | -0.71 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 822.31 M | 799.49 M | 746.64 M | 460.71 M |
| Operating Profit | -82.57 M | -77.72 M | -141.76 M | -28.87 M |
| Net Profit | -92.19 M | -126 M | -151.4 M | -19.75 M |
| EPS in Rs | -2.3 | -3.14 | -3.77 | -0.49 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 850.65 M | 893.29 M | 925.32 M | 458.63 M |
| Total Liabilities | 400.61 M | 390.17 M | 326.58 M | 121.77 M |
| Equity | 450.04 M | 503.12 M | 598.73 M | 336.86 M |
| Current Assets | 416.85 M | 433.29 M | 420.44 M | 255.99 M |
| Current Liabilities | 170.48 M | 168.63 M | 165.22 M | 83.62 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 33.35 M | 25.79 M | -45.75 M | -11.54 M |
| Investing CF | -34.6 M | -27.58 M | -33.13 M | -24.53 M |
| Financing CF | -0.79 M | 50.71 M | 65.32 M | -0.08 M |
| Free CF | -1.28 M | -9.09 M | -107.8 M | -34.7 M |
| Capex | -34.63 M | -34.88 M | -62.05 M | -23.16 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 7.08% | 62.06% | — | — |
| Earnings Growth % | 16.78% | -666.6% | — | — |
| Profit Margin % | -15.76% | -20.28% | -4.29% | — |
| Operating Margin % | -9.72% | -18.99% | -6.27% | — |
| Gross Margin % | 68.28% | 65.13% | 73.18% | — |
| EBITDA Margin % | -2.29% | -10.65% | 3.4% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.